1. Home
  2. KPRX vs YJ Comparison

KPRX vs YJ Comparison

Compare KPRX & YJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KPRX
  • YJ
  • Stock Information
  • Founded
  • KPRX 1998
  • YJ 2015
  • Country
  • KPRX United States
  • YJ China
  • Employees
  • KPRX N/A
  • YJ N/A
  • Industry
  • KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • YJ Other Specialty Stores
  • Sector
  • KPRX Health Care
  • YJ Consumer Discretionary
  • Exchange
  • KPRX Nasdaq
  • YJ Nasdaq
  • Market Cap
  • KPRX 9.1M
  • YJ 7.9M
  • IPO Year
  • KPRX N/A
  • YJ 2019
  • Fundamental
  • Price
  • KPRX $3.08
  • YJ $1.80
  • Analyst Decision
  • KPRX Strong Buy
  • YJ
  • Analyst Count
  • KPRX 1
  • YJ 0
  • Target Price
  • KPRX $10.00
  • YJ N/A
  • AVG Volume (30 Days)
  • KPRX 1.3M
  • YJ 11.9K
  • Earning Date
  • KPRX 05-09-2025
  • YJ 06-17-2025
  • Dividend Yield
  • KPRX N/A
  • YJ N/A
  • EPS Growth
  • KPRX N/A
  • YJ N/A
  • EPS
  • KPRX N/A
  • YJ N/A
  • Revenue
  • KPRX $20,000.00
  • YJ $57,219,520.00
  • Revenue This Year
  • KPRX N/A
  • YJ N/A
  • Revenue Next Year
  • KPRX N/A
  • YJ N/A
  • P/E Ratio
  • KPRX N/A
  • YJ N/A
  • Revenue Growth
  • KPRX N/A
  • YJ N/A
  • 52 Week Low
  • KPRX $2.51
  • YJ $1.37
  • 52 Week High
  • KPRX $5.55
  • YJ $3.16
  • Technical
  • Relative Strength Index (RSI)
  • KPRX 48.79
  • YJ 59.87
  • Support Level
  • KPRX $2.90
  • YJ $1.45
  • Resistance Level
  • KPRX $4.18
  • YJ $2.12
  • Average True Range (ATR)
  • KPRX 0.26
  • YJ 0.10
  • MACD
  • KPRX 0.00
  • YJ 0.03
  • Stochastic Oscillator
  • KPRX 19.12
  • YJ 52.24

About KPRX Kiora Pharmaceuticals Inc.

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.

About YJ Yunji Inc. American Depository Shares

Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in the PRC.

Share on Social Networks: